CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income (loss) and comprehensive income (loss)	$ 13,457	$ (10,826)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss on impairments and disposal of assets	5,027	431
Amortization of intangibles	2,049	7,917
Depreciation	4,795	4,854
Non-cash compensation expense	11,274	15,080
Deferred income taxes	360	326
Bad debt expense	963	850
Amortization of debt issuance costs	1,959	2,467
Write-off of previously-capitalized debt issuance costs	2,373	0
Amortization of debt discount	0	879
Reduction in carrying amount of ROU asset, offset by change in operating lease liabilities	(877)	(49)
Gain on settlement of convertible debt	(34,308)	0
Changes in current assets and liabilities:
Accounts receivable	(211)	(17,488)
Prepaid and other current assets	(1,882)	(3,666)
Accounts payable, accrued expenses and other current liabilities	8,559	9,322
Income taxes receivable	42	48
Other, net	(424)	(146)
Net cash provided by operating activities	13,156	9,999
Cash flows from investing activities:
Capital expenditures	(2,452)	(3,465)
Equity investments	0	(15,000)
Net cash used in investing activities	(2,452)	(18,465)
Cash flows from financing activities:
Repayment of term loan	(625)	0
Payments related to net-share settlement of stock-based compensation, net of proceeds from exercise of stock options	(1,693)	(3,085)
Purchase of treasury stock	0	(43,009)
Repurchase of 0.50% Convertible Senior Notes	(156,294)	0
Payment of debt issuance costs	(953)	(4)
Net cash used in financing activities	(159,565)	(46,098)
Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents	(148,861)	(54,564)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	298,969	251,342
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	$ 150,108	$ 196,778